Deka Bank Deutsche Girozentrale Exelixis, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Exelixis, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 429,690 shares of EXEL stock, worth $14.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

429,690

Previous 399,690 7.51%

Holding current value

$14.9 Million

Previous $8.95 Million 23.23%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$21.96 - $27.6 $658,800 - $828,000	30,000 Added 7.51%	429,690 $11 Million
Q2 2024 Aug 08, 2024	SELL	$20.34 - $23.73 $610,200 - $711,900	-30,000 Reduced 6.98%	399,690 $8.95 Million
Q1 2024 Apr 24, 2024	BUY	$20.17 - $23.93 $1 Million - $1.19 Million	49,597 Added 13.05%	429,690 $10 Million
Q4 2023 Jan 24, 2024	BUY	$19.25 - $24.13 $2.62 Million - $3.29 Million	136,194 Added 55.84%	380,093 $9.07 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $454,846 - $543,235	23,889 Added 10.86%	243,899 $5.42 Million
Q2 2023 Jul 25, 2023	BUY	$18.17 - $20.48 $152,900 - $172,339	8,415 Added 3.98%	220,010 $4.15 Million
Q1 2023 Apr 24, 2023	SELL	$16.3 - $19.41 $261,191 - $311,025	-16,024 Reduced 7.04%	211,595 $3.94 Million
Q3 2022 Nov 02, 2022	BUY	$15.68 - $22.27 $900,329 - $1.28 Million	57,419 Added 33.74%	227,619 $3.56 Million
Q1 2022 Apr 28, 2022	BUY	$17.03 - $22.67 $1.23 Million - $1.63 Million	72,000 Added 73.32%	170,200 $3.87 Million
Q4 2021 Feb 02, 2022	BUY	$15.84 - $21.88 $42,768 - $59,076	2,700 Added 2.83%	98,200 $1.89 Million
Q4 2020 Mar 12, 2021	SELL	$18.39 - $24.8 $88,272 - $119,040	-4,800 Reduced 4.79%	95,500 $1.91 Million
Q3 2020 Oct 29, 2020	BUY	$20.67 - $26.94 $2.07 Million - $2.7 Million	100,300 New	100,300 $2.42 Million
Q4 2019 Feb 04, 2020	SELL	$15.15 - $18.89 $1.52 Million - $1.89 Million	-100,100 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $1.88 Million - $2.41 Million	-106,300 Reduced 51.5%	100,100 $1.8 Million
Q2 2019 Aug 01, 2019	BUY	$18.93 - $24.75 $1.67 Million - $2.18 Million	88,100 Added 74.47%	206,400 $4.43 Million
Q1 2019 May 10, 2019	BUY	$19.6 - $24.76 $295,960 - $373,876	15,100 Added 14.63%	118,300 $2.28 Million
Q4 2018 Feb 12, 2019	SELL	$13.65 - $21.8 $206,115 - $329,180	-15,100 Reduced 12.76%	103,200 $1.99 Million
Q3 2018 Nov 09, 2018	SELL	$15.87 - $22.4 $49,197 - $69,440	-3,100 Reduced 2.55%	118,300 $0
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $148,480 - $179,600	8,000 Added 7.05%	121,400 $2.57 Million
Q1 2018 May 03, 2018	SELL	$22.15 - $31.89 $230,359 - $331,656	-10,400 Reduced 8.4%	113,400 $2.54 Million
Q3 2017 Nov 06, 2017	BUY	$23.35 - $29.24 $2.89 Million - $3.62 Million	123,800	123,800 $3.32 Million

Others Institutions Holding EXEL

# of Institutions

500

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.2B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Exelixis, Inc. Transaction History